Please login to the form below

Not currently logged in
Email:
Password:

Baxter recalls its heparin injection stock

Pharma company Baxter has voluntarily recalled stocks all of its heparin sodium injections following reports of potentially life-threatening side effects.

Pharma company Baxter has voluntarily recalled stocks all of its heparin sodium injections following reports of potentially life-threatening side effects.

Nine batches of heparin were initially recalled on January 17 but Baxter and the US Food and Drugs Administration (FDA) did not discontinue all stocks due to concerns about a shortage of blood thinners.

According to the FDA, the risk of patient's not being able to receive heparin sodium injections (blood thinners) far outweighed possible adverse patient reactions.

Peter Arduini, president of Baxter's Medication Delivery Business, said: "We have assurances from the FDA that there is an adequate supply in the market to meet the demand for these critical and lifesaving drugs."

Negative side effects have been found when heparin products are used during renal dialysis, invasive cardiovascular procedures, and apheresis procedures.

Patients given heparin multi-dose injections experienced reactions such as chest pains, rapid pulse, stomach pains and vomiting, as well as abnormal sensations of the skin.

The FDA said: "There have been reports of serious adverse events including allergic or hypersensitivity-type reactions.

"The manufacture of multiple-dose vials of heparin sodium has been suspended pending the completion of an extensive ongoing investigation to determine the root cause of the problem."

Customers are have been advised by Baxter to segregate and isolate heparin sodium injections and arrange for immediate return of the product to the manufacturer.

Arduini said: "The safety and quality of our products is always our highest priority, and we will continue to collaborate with the FDA as we work to determine the cause of the increased rate of adverse reactions."

29th February 2008

Share

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Spoonful of Sugar

Spoonful of Sugar (SoS) is a unique and diverse team of specialists in illness and medicines-related behaviour, hand-picked from academic,...

Latest intelligence

Market access in Europe: balancing access and affordability
European governments continue to pursue national agendas for market access, while also exploring opportunities to work together to achieve lower prices for new drugs...
Introduction to the manufacturing of biologics
The last decade has seen the rapid growth of biologics in the pharma market, making them a key sector to watch. With their growing popularity, it’s important to understand the...
CES 2017 – Medical Device Top Picks
Connected tech was the overriding theme at this year's Consumer Electronics Show in Las Vegas. But among all that consumer gadgetry, there were some great medical devices too. So what...

Infographics